Table 3 Association between CIP2A expression in patients with acute myeloid leukemia and the response to induction therapy and the relapse rate
From: Prognostic value of CIP2A gene expression in adult Egyptian acute myeloid leukemia patients
| Â | High CIP2A (n = 21) Distribution [n (%)] | Low CIP2A (n = 39) Distribution [n (%)] | P value | Relative risk (95% CI) |
|---|---|---|---|---|
Response to induction therapy | 0.57 | 1.2 (0.6–2.54) | ||
 Complete remission | 13 (61.9) | 27 (69.2) |  |  |
 Resistance | 8 (38.1) | 12 (30.8) |  |  |
Relapse | 0.27 | 0.4 (0.11–1.99) | ||
 Still in complete remission | 19 (90.5) | 31 (79.8) |  |  |
 Relapsed | 2 (9.5) | 8 (20.2) |  |  |